http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2800973-T3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_07c9542186133097bd6bbb7d92393090 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-0735 |
| filingDate | 2005-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-01-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_48a0f9ec7c391c6c5b6a4f06657fb546 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_05720eadcd04d4a01617ed1359216345 |
| publicationDate | 2021-01-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | ES-2800973-T3 |
| titleOfInvention | Primate embryonic stem cell culture |
| abstract | A culture medium comprising albumin, amino acids, vitamins, minerals, at least one transferrin or transferrin substitute, at least one insulin or insulin substitute, the culture medium free of animal serum and containing at least 100 ng / ml of a fibroblast growth factor selected from the group consisting of FGF4, FGF9, FGF17 and FGF18, the suitable medium for culturing primate embryonic stem cells in the absence of serum and in the absence of feeder cells and also in the absence of cell-exposed medium feeder, where at least 90% of the stem cells in the culture medium express Oct-4, SSEA4 or Tral-60. |
| priorityDate | 2004-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 342.